The impact of new tetralogy drugs on ventricular remodeling in heart failure patients: a systematic review and network meta-analysis
Xi-Wen Wang, Hao Li, Gan-Qi Wang, Ya-Nan Sheng, Xia Wang, Hui Pan, Zhi-Hao Wang, Wei Zhang, Yuan-Yuan Shang, Ming Zhong · 2025
Read The impact of new tetralogy drugs on ventricular remodeling in heart failure patients: a systematic review and network meta-analysis by Xi-Wen Wang, Hao Li, Gan-Qi Wang, Ya-Nan Sheng, Xia Wang, Hui Pan, Zhi-Hao Wang, Wei Zhang, Yuan-Yuan Shang, Ming Zhong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12754991.txt.
Description
Xi-Wen Wang and co-authors compare four modern heart failure drugs by how they reshape the heart in a 2025 review. The drug quartet has transformed care for weak hearts, yet which one best reverses the heart's harmful swelling and stretching was unsettled.
Twenty two trials with over sixteen thousand patients feed a network ranking. One class cut heart mass most. Another lifted pumping share past a rival class in indirect comparison. A third class shrank chamber size best on some reads. The mixed podium tells doctors to match drug strengths to each patient's remodeling pattern.
Catalog record
| CREATOR | Xi-Wen Wang, Hao Li, Gan-Qi Wang, Ya-Nan Sheng, Xia Wang, Hui Pan, Zhi-Hao Wang, Wei Zhang, Yuan-Yuan Shang, Ming Zhong |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |